Standard Biotools (LAB) Change in Acquisitions & Divestments (2011 - 2026)

Standard Biotools (LAB) has reported Change in Acquisitions & Divestments for 15 consecutive years, with $38.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 20.83% year-over-year to $38.0 million in Q2 2026; TTM through Jun 2026 was $132.0 million, a 37.14% decrease from a year earlier, with the FY2025 full-year figure at $179.0 million, down 48.71% from the prior year.
• Change in Acquisitions & Divestments was $38.0 million for Q2 2026 at Standard Biotools, up from $15.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $127.0 million in Q2 2024 and troughed at $12.0 million in Q3 2022.
• A 5-year average of $50.1 million and a median of $48.0 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments surged 210.03% in 2024 and sank 71.15% in 2026, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $41.0 million in 2022, then sank by 36.59% to $26.0 million in 2023, then surged by 130.77% to $60.0 million in 2024, then tumbled by 58.33% to $25.0 million in 2025, then soared by 52.0% to $38.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $38.0 million (Q2 2026), $15.0 million (Q1 2026), and $25.0 million (Q4 2025), per Business Quant data.